Gilead Sciences Diversifies into Kinase Biology
By Staff Editor
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 2 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1358 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Gilead Sciences, best known for its successful HIV portfolio, has made its first venture into the kinase arena by acquiring CGI Pharmaceuticals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS